-+ 0.00%
-+ 0.00%
-+ 0.00%
The Tokyo Stock Exchange saw Canvas in a buying mood in the afternoon after receiving approval from the European Medicines Agency to start Phase 3 clinical trials.
Share

Please log in to view news

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending